Figures & data
Table 1. Characteristics of included study.
Figure 2. The effectiveness of specific immunotherapy (SIT) on symptom scores. Results of the meta-analysis summarized in terms of effect size on symptoms. CI indicates confidence interval; SLIT, sublingual immunotherapy; SCIT, subcutaneous immunotherapy; and SMD, standardized mean difference.
![Figure 2. The effectiveness of specific immunotherapy (SIT) on symptom scores. Results of the meta-analysis summarized in terms of effect size on symptoms. CI indicates confidence interval; SLIT, sublingual immunotherapy; SCIT, subcutaneous immunotherapy; and SMD, standardized mean difference.](/cms/asset/ae7ba25a-1c6d-4e8f-b2ad-fe285182d9c8/ijas_a_2349604_f0002_b.jpg)
Figure 3. Forest plot of (a) medication score, (b) adverse events, and (c) the symptoms plus medication from the meta-analysis.
![Figure 3. Forest plot of (a) medication score, (b) adverse events, and (c) the symptoms plus medication from the meta-analysis.](/cms/asset/14f8e1c2-1f67-4b69-a638-e92509b1d5fb/ijas_a_2349604_f0003_b.jpg)
Figure 4. Forest plot of the (a) IgE levels, (b) IgG4 levels, and (c) FEV1 levels from the meta-analysis.
![Figure 4. Forest plot of the (a) IgE levels, (b) IgG4 levels, and (c) FEV1 levels from the meta-analysis.](/cms/asset/7ca18bf4-406f-4e49-83a9-eff404a54838/ijas_a_2349604_f0004_b.jpg)
Supplemental Material
Download MS Word (1.3 MB)Data availability statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.